Status:
UNKNOWN
Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction
Lead Sponsor:
Bubba Nicholson
Collaborating Sponsors:
Tampa General Hospital
Otrimed Clinical Research
Conditions:
Opioid Addiction
Opioid Abuse, Continuous Use
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
Healthy adult human male facial skin surface lipid liquid pheromone given by mouth to opioid addicts cures them without any withdrawal symptoms whatsoever 250mg on chewing gum vehicle by mouth. Elevat...
Detailed Description
Healthy adult human male facial skin surface lipid liquid pheromone given by mouth to opioid addicts cures them without any withdrawal symptoms whatsoever 250mg on chewing gum vehicle by mouth. Elevat...
Eligibility Criteria
Inclusion
- Dirty Tox Screen showing recent and continuing opioid drug dependence -
Exclusion
- Pregnant people, people who desire to retain their paraphilia
- \-
Key Trial Info
Start Date :
December 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03394911
Start Date
December 31 2020
End Date
November 1 2021
Last Update
October 19 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.